CRB Funded Projects

Projects are listed alphabetically by mechanism.

F32 - Postdoctoral Individual National Research Service Award
Project Number Description
1F32HD097932-01A1 YUEN, FIONA N
LA BIOMED RES INST/ HARBOR UCLA MED CTR
EXAMINING THE ANDROGENIC AND PROGESTATIONAL EFFECTS OF NOVEL ANDROGENS FOR MALE CONTRACEPTION
K23 - Mentored Patient-Oriented Research Devel Awd
Project Number Description
1K23HD094853-01A1 WILKINSON, TRACEY
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
A NAVIGATOR PROGRAM TO OVERCOME BARRIERS TO HORMONAL CONTRACEPTION
1K23HD097291-01 FRANCIS, JENNY KRISTINE RODRIGUEZ
UT SOUTHWESTERN MEDICAL CENTER
USE OF LONG-ACTING REVERSIBLE CONTRACEPTION
5K23HD090323-03 CHEN, MELISSA JOY
UNIVERSITY OF CALIFORNIA AT DAVIS
UNDERSTANDING THE LACTATIONAL AMENORRHEA METHOD OF CONTRACEPTION FOR MOTHERS OF PRETERM AND TERM INFANTS
K24 - Midcareer Investigator Awd in Patient-Oriented Res
Project Number Description
5K24HD082231-05 AMORY, JOHN K.
UNIVERSITY OF WASHINGTON
RETINOIC ACID IN MALE INFERTILITY
P01 - Research Program Projects
Project Number Description
5P01HD087157-03 MATZUK, MARTIN M
BAYLOR COLLEGE OF MEDICINE
FUNCTIONAL GENOMICS AND DEC-TEC TO IDENTIFY GERM CELL-SPECIFIC CONTRACEPTIVES
R01 - Research Project
Project Number Description
5R01HD083340-04 TUROK, DAVID
UNIVERSITY OF UTAH
RCT ASSESSING PREGNANCY WITH INTRAUTERINE DEVICES FOR EMERGENCY CONTRACEPTION
5R01HD084007-05 WANG, PEIJING JEREMY
UNIVERSITY OF PENNSYLVANIA
TARGETING THE PIRNA PATHWAY AND MEIOTIC RECOMBINATION FOR MALE CONTRACEPTION
5R01HD084046-05 PAYNE, CHRISTOPHER JESS
LURIE CHILDREN'S HOSPITAL OF CHICAGO
DEUBIQUITINATING ENZYMES AS TARGETS FOR MALE CONTRACEPTION
5R01HD085887-04 SCARSI, KIMBERLY K
UNIVERSITY OF NEBRASKA MEDICAL CENTER
PHARMACOLOGICAL STRATEGIES TO USE THE LEVONORGESTREL IMPLANT IN HIV-INFECTED WOMEN
5R01HD088279-03 TANG, JENNIFER
UNIV OF NORTH CAROLINA CHAPEL HILL
A PROSPECTIVE COHORT OF HIV-INFECTED MALAWIAN WOMEN ON EFAVIRENZ INITIATING THE LEVONORGESTREL IMPLANT OR THE DEPOT MEDROXYPROGESTERONE ACETATE INJECTABLE
5R01HD089957-03 EDELMAN, ALISON B
OREGON HEALTH & SCIENCE UNIVERSITY
IMPROVING EMERGENCY CONTRACEPTIVE EFFECTIVENESS IN OBESE WOMEN
5R01HD094634-02 CHERPES, THOMAS L.
STANFORD UNIVERSITY
ESTROGEN REVERSES PROGESTIN-MEDIATED LOSS OF GENITAL MUCOSAL BARRIER FUNCTION
5R01HD095341-02 GARCIA, THOMAS
BAYLOR COLLEGE OF MEDICINE
FUNCTIONAL GENOMICS AND PROTEOMICS TO REVEAL REPRODUCTIVE-TRACT SPECIFIC PROTEINS
5R01HD095630-03 ANDERSON, DEBORAH J
BOSTON UNIVERSITY MEDICAL CAMPUS
PROJECT THREE: ASSESSING EFFECTS OF ANTI-CD52G MABS ON STD PATHOGENS IN SEMEN
5R01HD095661-03 HIGGINS, JENNY A.
UNIVERSITY OF WISCONSIN-MADISON
SEXUAL ACCEPTABILITY'S ROLE IN WOMEN'S CONTRACEPTIVE PREFERENCE AND BEHAVIOR
5R01HD096937-02 DEESE, JENNIFER CARAWAY
FAMILY HEALTH INTERNATIONAL
UNDERSTANDING THE IMPACT OF LOWER DOSE MEDROXYPROGESTERONE ACETATE ON FEMALE GENITAL TRACT MICROBIOME AND IMMUNOLOGY
R21 - Exploratory/Developmental Grants
Project Number Description
5R21HD095708-02 DEESE, JENNIFER CARAWAY
FAMILY HEALTH INTERNATIONAL
CONTRACEPTIVE METHOD AND HIV RISK
R42 - * Small Business Technology Transfer (STTR) Grants - Phase II
Project Number Description
5R42HD084077-03 ORAND, MICHAEL GENE
EPPIN PHARMA, INC.
TESTING A MALE ORAL CONTRACEPTIVE TARGETING EPPIN
R43 - Small Business Innovation Research Grants (SBIR) - Phase I
Project Number Description
1R43HD097820-01 ORAND, MICHAEL GENE
EPPIN PHARMA, INC.
DRUG INTERACTIONS IN VITRO FOR EP055: A NON-HORMONAL MALE CONTRACEPTIVE
top of pageBACK TO TOP